As of 2024-12-15, the EV/EBITDA ratio of Amneal Pharmaceuticals Inc (AMRX) is
4.79.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Amneal's latest enterprise value
is 2,423.70 mil USD. Amneal's TTM EBITDA according to its financial statements is
506.31 mil USD. Dividing these 2
quantities gives us the above Amneal EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
8.1x - 11.4x |
10.6x |
| Forward P/E multiples |
11.2x - 12.3x |
11.8x |
| Fair Price |
2.71 - 18.61 |
10.09 |
| Upside |
-65.3% - 137.7% |
28.9% |